BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24619149)

  • 1. Lentiviral vectors for the treatment of primary immunodeficiencies.
    Farinelli G; Capo V; Scaramuzza S; Aiuti A
    J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of gene therapy for primary immune deficiencies.
    Aiuti A; Roncarolo MG
    Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of primary T cell immunodeficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
    Candotti F
    Int J Hematol; 2014 Apr; 99(4):383-92. PubMed ID: 24488786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for primary immunodeficiencies: Part 2.
    Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
    Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of inherited immunodeficiencies.
    Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
    Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapies for Primary Immune Deficiencies.
    Kohn LA; Kohn DB
    Front Immunol; 2021; 12():648951. PubMed ID: 33717203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for primary adaptive immune deficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
    Uchiyama T; Onodera M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):148-55. PubMed ID: 23812072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.
    Carbonaro DA; Zhang L; Jin X; Montiel-Equihua C; Geiger S; Carmo M; Cooper A; Fairbanks L; Kaufman ML; Sebire NJ; Hollis RP; Blundell MP; Senadheera S; Fu PY; Sahaghian A; Chan RY; Wang X; Cornetta K; Thrasher AJ; Kohn DB; Gaspar HB
    Mol Ther; 2014 Mar; 22(3):607-622. PubMed ID: 24256635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Results with Ex Vivo Lentiviral HSPC Gene Therapy in ADA-SCID.
    Am J Med Genet A; 2021 Aug; 185(8):2291-2292. PubMed ID: 34240545
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for severe combined immunodeficiencies and beyond.
    Fischer A; Hacein-Bey-Abina S
    J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Gene Therapy in Primary Immunodeficiency.
    Thrasher AJ; Williams DA
    Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects: gene therapy for inherited immunodeficiencies.
    Qasim W; Gaspar HB; Thrasher AJ
    Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency.
    Montiel-Equihua CA; Thrasher AJ; Gaspar HB
    Curr Gene Ther; 2012 Feb; 12(1):57-65. PubMed ID: 22348551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
    Sauer AV; Di Lorenzo B; Carriglio N; Aiuti A
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):527-34. PubMed ID: 25207699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
    Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of gene therapy for primary immunodeficiencies.
    Cicalese MP; Aiuti A
    Hum Gene Ther; 2015 Apr; 26(4):210-9. PubMed ID: 25860576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.